Treatment of Redo-microvascular Decompression or Internal Neurolysis Plus Microvascular Decompression for Recurrent Trigeminal Neuralgia: a Review of Long-term Effectiveness and Safety
Overview
Authors
Affiliations
Objective: We examined the clinical characteristics and outcomes of patients with recurrent trigeminal neuralgia (TN) and assessed the long-term efficacy and safety of microvascular decompression (MVD) to treat typical recurrent TN.
Methods: We identified 3024 patients who underwent MVD for treatment of TN at the China-Japan Friendship Hospital from March 2009 to December 2020. We retrospectively analyzed the data and outcomes of 137 patients who underwent redo-MVD and 74 patients who did not undergo redo-MVD as the control group. These outcomes were evaluated using the Barrow Neurological Institute scoring system.
Results: Recurrence in 68 of the 137 patients was due to incomplete or absent decompression or new responsible vessels. To ensure thorough pain relief, redo-MVD should include decompression of both the trigeminal root entry zone and the peripheral nerve segments, where blood vessels can cause symptoms. Factors associated with reduced effectiveness of redo-MVD were no period of initial pain relief after the first MVD and a longer duration of symptoms before the first MVD.
Conclusions: Redo-MVD should not be excluded as a treatment option for patients with refractory TN who develop recurrent pain after a first MVD procedure.
Paolini S, Mancarella C, Scafa A, Arcidiacono U, Morace R, Chiarella V Neurosurg Rev. 2025; 48(1):32.
PMID: 39789374 DOI: 10.1007/s10143-024-03100-w.
Pathophysiology and Management of Refractory Trigeminal Neuralgia.
Stern J, Ali R, Chiang C, Robertson C Curr Neurol Neurosci Rep. 2024; 25(1):10.
PMID: 39665844 DOI: 10.1007/s11910-024-01387-2.
Association of concomitant continuous pain in trigeminal neuralgia with a narrow foramen ovale.
Li S, Liao C, Yang X, Zhang W Front Neurol. 2023; 14:1277654.
PMID: 38020635 PMC: 10644226. DOI: 10.3389/fneur.2023.1277654.